Size-dependent antimicrobial properties of sugar-encapsulated gold nanoparticles synthesized by a green method
- Vivek D Badwaik†1,
- Lakshmisri M Vangala†1,
- Dillon S Pender1,
- Chad B Willis1,
- Zoraida P Aguilar2,
- Matthew S Gonzalez1,
- Rammohan Paripelly1 and
- Rajalingam Dakshinamurthy1Email author
© Badwaik et al.; licensee Springer. 2012
Received: 6 August 2012
Accepted: 31 October 2012
Published: 12 November 2012
The antimicrobial properties of dextrose-encapsulated gold nanoparticles (dGNPs) with average diameters of 25, 60, and 120 nm (± 5) and synthesized by green chemistry principles were investigated against both Gram-negative and Gram-positive bacteria. Studies were performed involving the effect of dGNPs on the growth, morphology, and ultrastructural properties of bacteria. dGNPs were found to have significant dose-dependent antibacterial activity which was also proportional to their size. Experiments revealed the dGNPs to be bacteriostatic as well as bactericidal. The dGNPs exhibited their bactericidal action by disrupting the bacterial cell membrane which leads to the leakage of cytoplasmic content. The overall outcome of this study suggests that green-synthesized dGNPs hold promise as a potent antibacterial agent against a wide range of disease-causing bacteria by preventing and controlling possible infections or diseases.
KeywordsGold nanoparticles Green synthesis Antibacterial activity Propidium iodide Outer membrane vesicles
Multidrug-resistant (MDR) bacteria represent a major threat to the success of many branches of medical sciences. Some patients are especially vulnerable of acquiring MDR bacterial infections as a consequence of treatments for illnesses such as organ transplant, hemodialysis, and various types of cancer. Each year at least 150,000 people die around the world due to the infection of a particular MDR bacterium. Therefore, there is an immense need for new strategies to design antibacterial agents.
Nanoparticles (NPs) have been used to synthesize or to improve the remedial efficacy of antibacterial agents[4–10]. NPs for this purpose are generally synthesized by using various metals and polymers[11, 12]. ZnO nanoparticles have been used as an antibacterial agent but, published studies also showed that ZnO nanoparticles were toxic to T cells and neuroblastoma cells[13, 14]. Copper nanoparticles have been shown as a potential antimicrobial agent, but it also comes with the cost of toxicity to eukaryotic cells e.g., potential damage to dorsal root ganglion neuron[15, 16]. Similarly, silver nanoparticles have been studied extensively for their potential antibacterial properties, but many concerns arises over their use on mammalian cells due to the essential toxicity of silver e.g., the genotoxicity towards mammalian cell lines such as mouse embryonic stem cells and mouse embryonic fibroblasts[18, 19]. The use of silver nanoparticles for medical applications is potentially limited due to their nonspecific biological toxicity. Compared to all the metal nanoparticles mentioned above, gold nanoparticles are more amenable to surface modification and are also photostable, and nontoxic based on the extensive review on nanotechnology[20, 21].
Thus, where the undesirable properties such as cellular toxicity and instability of these NPs limit their application, the gold nanoparticles (GNPs) have attracted a significant interest because of their convenient surface bioconjugation, remarkable plasmon-resonant optical properties, chemical stability, and non-toxicity[22–25]. Studies have also shown that the GNPs are useful to improve the efficacy, delivery, target specificity, and biodistribution of the drugs which enhance the antibacterial activity against MDR bacteria[11–14]. However, the use of complicated non-bio/non-ecofriendly chemical synthesis processes and dependence on external sources (such as laser pulses) for the synthesis and/or the activation of GNPs limits their environmental/biocompatibility[26–30]. Moreover, the size of the GNPs strongly influences their physical, chemical, and biological properties[31, 32]. Therefore, there is a need for GNPs with different sizes for various biomedical applications including those with antibacterial activity.
This report is focused on the antibacterial activity of the dextrose-encapsulated gold nanoparticles (dGNPs) which were synthesized by employing a ‘completely green’ method as shown in our previously published article. In this context ‘green’ refers to the process in which the dGNPs were synthesized. The green process is completely natural allowing for the reproducible synthesis of differently sized dGNPs without the need for harsh chemicals or expensive equipment such as lasers. The advantages of said ‘green techniques’ are linked with natural, inexpensive, chemical stability, and ecofriendliness. Three different sizes of dGNPs were synthesized having the average diameters of 25, 60, and 120 nm (±5). The resulting dGNPs were nearly spherical, monodispersed, stable, and water soluble. The dGNPs were prepared using dextrose as both reducing and capping agent.
We explored the antibacterial activity of the dGNPs against both Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus epidermidis) bacteria. Investigation of the bacterial growth kinetics and growth inhibition, in the presence of dGNPs at various concentrations, was performed using a real-time spectrophotometric assay. Antibacterial activity and efficacy were further validated by turbidimetry and spread plate assays. To understand the mechanism of action, we performed fluorescence microscopy and observed ultrathin slices of nanoparticles-treated bacterial cells under transmission electron microscope (TEM).
Chemicals including KAuCl4/HAuCl4, Luria-Bertani broth, Luria broth (LB) agar, tryptic soy agar, propidium iodide, and dextrose were purchased from Aldrich, St. Louis, MO, USA. E. coli and S. epidermidis were purchased from Invitrogen, Carlsbad, CA, USA or obtained from Western Kentucky University’s culture collection. Analytical grade chemicals were typically used.
Synthesis and characterization of dGNPs
Gold nanoparticles were synthesized according to our previously published environmentally benign, biofriendly, single-step/single-phase synthesis method. In this method dextrose was used as a reducing agent as well as a capping agent causing the reduction of Au3+ ions in an aqueous buffer at room temperature and atmospheric pressure. In a typical dGNPs sample, preparation process the reaction mixture was centrifuged at 6,000 rpm for 20 min, and the supernatant was discarded. The precipitated dGNPs were resuspended in autoclaved nanopure water and then again precipitated by centrifugation (and the supernatant was discarded). This resuspension and precipitation processes were repeated at least four times and then the dGNPs samples were used for further analysis. This washing procedure helped us to make sure that the dGNPs sample does not contain any free dextrose or any free Au ions. The synthesized dGNPs were characterized using various analytical techniques including TEM analysis (Section A in Additional file1). To determine the morphology of dGNPs, the absorption spectra were observed using Perkin Elmer Lambda 35 UV/vis spectrophotometer (Perkin Elmer Inc., Waltham, MA, USA). Energy dispersive spectroscopy was performed to analyze the elemental composition of nanoparticles using JEOL JSM 5400 LV with IXRF system (JEOL Ltd., Tokyo, Japan). Quantification of dGNPs was performed using the reported methods[3, 34–38] (Section B in Additional file1). The presence of dextrose on the surface of dGNP was further confirmed by Benedict’s test (Section C in Additional file1).The presence of hydroxyl group was determined by treatment with acetic anhydride and pyridine followed by titration with sodium hydroxide (Section D Additional file1). The more detailed experimental procedure for quantification, Benedict’s test, and volumetric titration are described in the additional word file (Additional file1).
Determination of antibacterial activity of dGNPs
The antibacterial experiments were performed using fresh culture of bacteria obtained by inoculating 100 μL of bacterial glycerol stock into 10 mL of sterile LB or minimal liquid medium in a culture tube. The bacteria were allowed to grow overnight in an incubator maintained at 37°C and shaken at 150 rpm. For all the experiments, dGNPs were washed several times with sterile water and then resuspended in nanopure water or medium.
Turbidimetry refers to a microbiological assay performed for measuring the minimum inhibitory concentration (MIC) of dGNPs against E. coli. Various concentrations of dGNPs with average diameters of 120 nm (2 × 1010, 4 × 1010, 8 × 1010, 16 × 1010 NPs/mL), 60 nm (2 × 1011, 4 × 1011, 8 × 1011, 16 × 1011 NPs/mL), 25 nm (16 × 1012, 32 × 1012, 64 × 1012, 128 × 1012 NPs/mL) were inoculated with 1 × 106 CFU/mL in a series of culture tubes containing 4 mL of sterile liquid media. Control experiments were performed by inoculating the media with E. coli in the absence of dGNPs. All tubes were incubated at 37°C, and the growth of bacteria was monitored by measuring the optical density (OD) at 600 nm for 12 h. OD 600 is an acronym indicating the optical density of a sample measured at a wavelength of 600 nm. Optical density at 600 nm is a common method used in molecular biology to quantify the bacteria by determining the absorbance at 600 nm[39, 40].
Spread plate technique
The bacteria (E. coli/S. epidermidis) were grown in a series of culture tubes containing 4 mL of sterile liquid media with various concentrations of dGNPs. Cultures from selected concentrations and growth points (12 h) were spread onto LB or tryptic soy agar plates and incubated at 37°C for 12 h to estimate the number of viable bacteria.
The bacteria were cultured in liquid media in the presence of different concentrations of dGNPs for 12 h at 37°C. The samples were collected and centrifuged at 6,000 rpm for 3 min and washed twice with phosphate buffered saline (PBS, pH ~ 7.2). These bacterial cells were incubated with propidium iodide (3 μM in PBS) in the dark for 30 min at room temperature. Fluorescence detection was performed on 10 μL of the bacterial suspension that was placed on a glass slide and observed under Leica scanning fluorescence microscope (Leica Microsystems, Buffalo Grove, IL, USA). Positive control was prepared by treating the bacterial suspension with 100% ethyl alcohol for 15 min.
Preparation for cross section of the bacterial cells
Ultrastructural changes induced by dGNP treatment were studied under an electron microscope. The cultures of the two bacterial strains were fixed by mixing with equal volumes of a × 2 fixative solution to give final concentrations of 2.0% w/v paraformaldehyde and 2.5% w/v glutaraldehyde in 50 mM sodium cacodylate buffer (pH 7.4). After incubating with fixative for 2 h at room temperature, the fixed samples were washed and centrifuged twice; the supernatant was discarded, and the pellet was resuspended in 50 mM sodium cacodylate buffer. The same process was followed during all subsequent solution changes. Samples were post-fixed for 1 h at 25°C with 1% w/v osmium tetroxide in 50 mM sodium cacodylate buffer. The post-fixed samples were washed with nanopure water twice and then dehydrated in a graded ethanol series (once in 25%, 50%, 75%, and 95%, and thrice in 100% ethanol for 10 min each). The dehydrated samples were infiltrated with Spurr’s epoxy resin (once in 33%, 66%, 95%, and thrice in 100% resin for 1 h each) and then left overnight in 100% resin. The samples were centrifuged through fresh resin in BEEM capsules (BEEM Inc., West Chester, PA, USA) and hardened at 70°C for 18 h. Ultrathin sections of the pelleted samples were cut on an RMC MT-X ultra-microtome using a glass knife. The sections were stained with 2% aqueous uranyl acetate and Reynold’s lead citrate for 15 and 3 min, respectively and examined using a JEOL-100CX transmission electron microscope[42, 43].
Results and discussion
Recent advances in the field of nanobiotechnology have been used for the development of new antibacterial agents. Non-bio/ non-ecofriendly synthesis processes, cellular toxicity, and instability of nanoparticles severely limit the nanoparticles application. Taking this into consideration, we explored the antibacterial properties of stable, biocompatible, ecofriendly dGNPs.
Synthesis and characterization of dGNPs
Three different sizes of dGNPs [25, 60, and 120 nm (±5)] were synthesized using the previously published method in which dextrose was used as a capping and reducing agent (see Section A in Additional file1). The dGNPs of different sizes were produced by varying the concentrations of KAuCl4.
The antibacterial activity exhibited by dGNPs could be attributed to the presence of free Au3+ ions that remained in the solution when the dGNPs were suspended in water or due to changes in pH, since the bacterial activity is sensitive to both of these factors. To quantify the free Au3+ ions in the suspension, the dGNPs precipitated by centrifugation and the supernatant was tested for the presence of free Au3+ ions by measuring the absorbance at 290 nm. The near zero absorbance at 290 nm showed the absence of any free Au3+ ion (data not shown), suggesting that the free Au3+ ions concentration in the dGNPs suspension was insignificant and therefore, not responsible for the antibacterial activity. In addition the pH of the dGNPs suspensions was near 7.2 to 7.4 which is the normal pH range for the microorganism environment. Hence, the pH could not have been responsible for the antibacterial activity. Taken together, the results suggested that the antibacterial activity was solely due to the dGNPs and not due to free Au3+ ion or changes in pH.
dGNPs-induced disruption of bacterial cells
The overall results suggested similar potency and membrane disruption process for the antibacterial activity of dGNPs towards Gram-negative as well as Gram-positive bacteria. Dextrose is a polyhydroxylated molecule, which can act both as a hydrogen bond donor as well as a hydrogen bond acceptor. The presence of the capping ligand dextrose was confirmed with positive Benedict’s test (Section C in Additional file1). The hydroxyl group was also detected using acetylation reaction followed by volumetric titration with sodium hydroxide (Section D in Additional file1). The presence of hydroxyl group can thus be attributed for the strong electrostatic interaction between dGNPs and both Gram-negative or Gram-positive bacteria, which in turn lead to the disruption of cell membrane. Thus, this may explain the versatile antibacterial activity of these dGNPs. It may be inferred that the ligand molecule dextrose plays a crucial role in the antibacterial action but the mechanism of interaction remains to be established.
In this present work, we have investigated the antibacterial activity of biofriendly/ecofriendly dextrose-encapsulated GNPs of sizes 25, 60, and 120 nm (± 5). These green-synthesized dGNPs showed significant antibacterial activity against both Gram-negative as well as Gram-positive bacteria. The efficiency of antibacterial activity was directly proportional to the increase in size as well as the concentration of dGNPs. These dGNPs were found to exert their antibacterial action via disruption of the cell membrane leading to possible leakage of the cytoplasmic contents including nucleic acids. Based on the results, it is plausible that the amphoteric nature of dextrose (the capping ligand) might be responsible for the interaction of dGNPs with both the Gram-positive and Gram-negative bacteria which, in turn, leads to the antibacterial activity. The antibacterial properties of the dGNPs hold promise for pharmaceutical, disinfectant, and other biomedical applications. The molecular level interaction between the cell membrane and the dGNPs that causes membrane rupture remains to be established.
We are grateful to Dr. John Andersland for TEM analysis. The project was supported in part by Department of Chemistry, Advanced Materials Institute, Ogden College of Science and Engineering, Office of Sponsored Programs at Western Kentucky University and grants from the National Center for Research Resources (5P20RR016481-12) and the National Institute of General Medical Sciences (8 P20 GM103436-12) from the National Institutes of Health and National Science Foundation Research Experience for Undergraduates (REU) grant number EAR-1004655. The honors college grant to DSP and the graduate student research grants to VDB and LMV are also appreciated.
- So AD, Gupta N, Brahmachari SK, Chopra I, Munos B, Nathan C, Outterson K, Paccaud JP, Payne DJ, Peeling RW, Spigelman M, Weigelt J: Towards new business models for R&D for novel antibiotics. Drug Resist Update 2011, 14: 89–94.
- Salerno F, Cazzaniga M: Therapeutic strategies and emergence of multiresistant bacterial strains. Intern Emerg Med 2010, 5: 45–51. 10.1007/s11739-010-0447-9View Article
- Zhao Y, Tian Y, Cui Y, Liu W, Ma W, Jiang J: Small molecule-capped gold nanoparticles as potent antibacterial agents that target gram-negative bacteria. J Am Chem Soc 2010, 132: 12349–12356. 10.1021/ja1028843View Article
- Balland O, Pinto-Alphandary H, Viron A, Puvion E, Andremont A, Couvreur P: Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H) ampicillin-loaded nanoparticles. J Antimicrob Chemother 1996, 37: 105–115.View Article
- Rosemary MJ, MacLaren I, Pradeep T: Investigations of the antibacterial properties of ciprofloxacin@SiO2. Langmuir 2006, 22: 10125–10129. 10.1021/la061411hView Article
- Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, Mirkin CA: Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312: 1027–1030. 10.1126/science.1125559View Article
- Thomas M, Klibanov AM: Conjugation to gold nanoparticles enhances polyethylenimine’s transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA 2003, 100: 9138–9143. 10.1073/pnas.1233634100View Article
- Cho EC, Au L, Zhang Q, Xia Y: The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small 2010, 6: 517–522. 10.1002/smll.200901622View Article
- Bowman MC, Ballard TE, Ackerson CJ, Feldheim DL, Margolis DM, Melander C: Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 2008, 130: 6896–6897. 10.1021/ja710321gView Article
- Gu H, Ho PL, Tong E, Wang L, Xu B: Using biofunctional magnetic nanoparticles to capture vancomycin-resistant Enterococci and other gram-positive bacteria at ultralow concentration. Nano Lett 2003, 3: 1261–1263. 10.1021/nl034396zView Article
- Buzea C, Pacheo I, Robbie K: Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007, 2: 2815690–2815745.View Article
- Nair LS, Laurencin CT: Role of size scale of ZnO nanoparticles and microparticles on toxicity towards bacteria and osteoblast cancer cells. J Biomed Nanotechnol 2007, 3: 301–316. 10.1166/jbn.2007.041View Article
- Reddy KM, Feris K, Bell J, Wingett DG, Hanley C, Punnoose A: Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl Phy Lett 2007, 90: 213902. 10.1063/1.2742324View Article
- Jeng HA, Swanson J: Toxicity of metal oxide nanoparticles in mammalian cells. J Enviorn Sci Health 2006, 41: 2699.View Article
- Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S: Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 2008, 4: 707–716. 10.1016/j.actbio.2007.11.006View Article
- Prabhu BM, Ali SF, Murdock RC, Hussain SM, Srivatsan M: Copper nanoparticles exert size and concentration dependent toxicity on somatosensory neurons of rat. Nanotoxicology 2010, 4: 150–160. 10.3109/17435390903337693View Article
- Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, Yacaman M: The bactericidal effect of silver nanoparticles. J. Nanotechnology. 2005, 16: 2346–2353. 10.1088/0957-4484/16/10/059View Article
- Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, Hong Y: DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 2008, 233: 404–410. 10.1016/j.taap.2008.09.015View Article
- Norman RS, Stone JW, Gole A, Murphy CJ, Sabo ATL: Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, by gold nanorods. Nano Lett 2008, 8: 302–306. 10.1021/nl0727056View Article
- Panyala N, Pena-Mendze E, Havel J: Silver or silver nanoparticles: a hazardous threat to the environment and human health? Jour of App Biomed. 2008, 6: 117–129.
- Love JC, Estroff LA, Kriebel JK, Nuzzo RG, Whitesides GM: Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev 2005, 105: 1103–1170. 10.1021/cr0300789View Article
- Cheng CMM, Cuda G, Bunimovich LY, Gaspari M, Heath RJ, Hill DH, Mirkin AC, Nijdam JA, Terracciano R, Thundat T, Ferrari M: Nanotechnologies for biomolecular detection and medical diagnostics. Curr Opin Chem Biol 2006, 10: 11–19. 10.1016/j.cbpa.2006.01.006View Article
- Hu M, Chen J, Li ZY, Au L, Hartland GV, Li X, Marqueze M, Xia Y: Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem Soc Rev 2006, 35: 1084–1094. 10.1039/b517615hView Article
- Shim SY, Lim DK, Nam JM: Ultrasensitive optical biodiagnostic methods using metallic nanoparticles. Nanomedicine 2008, 3: 215–232. 10.2217/174358188.8.131.52View Article
- Huang WC, Tsai PJ, Chen YC: Functional gold nanoparticles as photothermal agents for selective-killing of pathogenic bacteria. Nanomedicine 2007, 2: 777–787. 10.2217/174358184.108.40.2067View Article
- Kovtun A, Heumann R, Epple M: Calcium phosphate nanoparticles for the transfection of cells. Biomed Mater Eng 2009, 19: 241–247.
- Bunz UH, Rotello VM: Gold nanoparticle-fluorophore complexes: sensitive and discerning “noses” for biosystems sensing. Angew Chem Int Ed Engl 2010, 49: 3268–3279. 10.1002/anie.200906928View Article
- Wu W, Li AD: Research focus: optically switchable nanoparticles for biological imaging. Nanomedicine 2007, 2: 523–531. 10.2217/174358220.127.116.113View Article
- Liao HW, Nehl CL, Hafner JH: Biomedical applications of plasmon resonant metal nanoparticles. Nanomedicine 2006, 1: 201–208. 10.2217/17435818.104.22.168View Article
- Erathodiyil N, Ying JY: Functionalization of inorganic nanoparticles for bioimaging applications. Acc Chem Res 2011, 44: 925–935. 10.1021/ar2000327View Article
- Kelly LK, Coronado E, Zhao L, Schatz GC: The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment. J Phys Chem B 2003, 107: 668–677.View Article
- Auffan M, Bottero YJ, Chaneac C, Rose J: Inorganic manufactured nanoparticles: how their physicochemical properties influence their biological effects in aqueous environments. Nanomedicine 2010, 5: 999–1007. 10.2217/nnm.10.61View Article
- Pal S, Yu KT, Song M: Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. J Appl Environ Microbiol 2007, 73: 1712–1720. 10.1128/AEM.02218-06View Article
- Badwaik DV, Bartonojo JJ, Evans WJ, Sahi VS, Willis BC, Dakshinamurthy R: Single-step bio-friendly synthesis of surface modifiable, near-spherical gold nanoparticles for applications in biological detection and catalysis. Langmuir 2011, 27: 5549–5554. 10.1021/la105041dView Article
- Robert DS, Robert LH, Martha V: Benedict’s solution, a reagent for measuring reducing sugars: the clinical chemistry of Stanley R. Benedict J Biol Chem 1908, 5: 485–487.
- Vernon LP, Edward SW: The volumetric estimation of hydroxyl groups in sugars and other organic compounds. J Biol Chem 1927, 74: 379–383.
- Daniel MC, Ruiz J, Nlates S, Blais JC, Astrus D: Nanoscopic assemblies between supramolecular redox active metallodendrons and gold nanoparticles: synthesis, characterization, and selective recognition of H2PO4−, HSO4−, and adenosine-5′-triphosphate (ATP2−) anions. J Am Chem Soc 2003, 125: 2617–2628. 10.1021/ja021325dView Article
- Leff DV, Ohara PC, Heath JR, Gelbart WM: Crystallization of opals from polydisperse nanoparticles. J Phys Chem 1995, 99: 7036–7041. 10.1021/j100018a041View Article
- Chamundeeswari M, Sobhana LSS, Jacob PJ, Kumar GM, Devi PM, Sastry PT, Mandal BA: Preparation, characterization and evaluation of a biopolymeric gold nanocomposite with antimicrobial activity. Biotechnol Appl Biochem 2010, 55: 29–35. 10.1042/BA20090198View Article
- Burygin LG, Khlebtsov NB, Shantrokha NA, Dykman AL, Bogatyrev AV, Khlebtsov GN: On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale Res Lett 2009, 4: 794–801. 10.1007/s11671-009-9316-8View Article
- Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D: Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 2007, 18: 225103–225112. 10.1088/0957-4484/18/22/225103View Article
- Santhana RL, Hing HL, Baharudin O, Teh HZ, Aida SR, Nor ACP, Vimala B, Paramsarvaran S, Sumarani G, Hanjeet K: Rapid method for transmission electron microscope study of Staphylococcus aureus ATCC 25923. Ann Microscope 2007, 7: 102–108.
- Jung KW, Koo CH, Kim WK, Shin S, Kim HS, Park HY: Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 2008, 74: 2171–2178. 10.1128/AEM.02001-07View Article
- Kadurugamuwa JL, Clarke AJ, Beveridge TJ: Surface action of gentamicin on Pseudomonas aeruginosa. J Bacteriology 1993, 175: 5798–5805.
- Vaara M: Agents that increase the permeability of the outer membrane. Microbiol Rev 1992, 56: 395–411.
- Lowy DF: Staphylococcus aureus infections. N Engl J Med 1998, 339: 520–532. 10.1056/NEJM199808203390806View Article
- Ryan KJ, Ray CG: An introduction to infectious diseases. Medical Microbiology. 2004, 4: 345–347.
- Ndeke M, Melusi T, Nomakhwezi N: The antibacterial effects of engineered nanomaterials: implications for wastewater treatment plants. J Enviorn Monitor 2011, 13: 1164–1183. 10.1039/c1em10023hView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.